Exane Derivatives’s LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) LTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-93,428
Closed -$764K 701
2016
Q4
$764K Buy
93,428
+9,897
+12% +$88K 0.15% 108
2016
Q3
$678K Buy
83,531
+13,759
+20% +$113K 0.1% 134
2016
Q2
$460K Buy
69,772
+21,689
+45% +$143K 0.08% 133
2016
Q1
$337K Buy
48,083
+1,827
+4% +$10.6K 0.04% 160
2015
Q4
$249K Sell
46,256
-73,638
-61% -$404K 0.03% 149
2015
Q3
$585K Buy
119,894
+14,499
+14% +$84.2K 0.07% 115
2015
Q2
$742K Sell
105,395
-50,894
-33% -$435K 0.08% 113
2015
Q1
$1.26M Buy
156,289
+6,487
+4% +$66.1K 0.14% 85
2014
Q4
$1.79M Buy
+149,802
New +$1.73M 0.25% 73

Other funds holding LTM

Exane Derivatives's LTM Position: Q1 2017 in Review

Exane Derivatives sold out of LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) (LTM) in Q1 2017, closing a stake of 93,428 shares — an estimated $764K sold.

Exane Derivatives first reported a position in LTM in Q4 2014 and held it in 9 quarters. The position peaked at $1.79M in Q4 2014. 73 funds tracked by Wall St. Rank hold LTM as of Q1 2017.

  • Exane Derivatives reported no remaining LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 93,428 LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) shares in Q1 2017, an estimated $764K.
  • Exane Derivatives first reported a position in LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) in Q4 2014 and held it in 9 quarters.
  • Exane Derivatives's LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) position peaked at $1.79M in Q4 2014.
  • 73 funds tracked by Wall St. Rank held LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share) as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.